Bohm S - Search Results

1

Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer.

Di Re F, Bohm S, Oriana S, Spatti GB, Zunino F. Di Re F, et al. Among authors: bohm s. Cancer Chemother Pharmacol. 1990;25(5):355-60. doi: 10.1007/BF00686237. Cancer Chemother Pharmacol. 1990. PMID: 2306797

2

Peripheral neurotoxicity following high-dose cisplatin with glutathione: clinical and neurophysiological assessment.

Pirovano C, Balzarini A, Böhm S, Oriana S, Spatti GB, Zunino F. Pirovano C, et al. Among authors: bohm s. Tumori. 1992 Aug 31;78(4):253-7. doi: 10.1177/030089169207800408. Tumori. 1992. PMID: 1334604

3

A feasibility study of cisplatin administration with low-volume hydration and glutathione protection in the treatment of ovarian carcinoma.

Bohm S, Battista Spatti G, Di Re F, Oriana S, Pilotti S, Tedeschi M, Tognella S, Zunino F. Bohm S, et al. Anticancer Res. 1991 Jul-Aug;11(4):1613-6. Anticancer Res. 1991. PMID: 1746919

4

Glutathione and detoxification.

Tedeschi M, Bohm S, Di Re F, Oriana S, Spatti GB, Tognella S, Zunino F. Tedeschi M, et al. Among authors: bohm s. Cancer Treat Rev. 1990 Sep;17(2-3):203-8. doi: 10.1016/0305-7372(90)90048-k. Cancer Treat Rev. 1990. PMID: 2272034 Review. No abstract available.

5

A preliminary clinical experience with reduced glutathione as protector against cisplatin-toxicity.

Oriana S, Böhm S, Spatti G, Zunino F, Di Re F. Oriana S, et al. Among authors: bohm s. Tumori. 1987 Aug 31;73(4):337-40. doi: 10.1177/030089168707300403. Tumori. 1987. PMID: 3660470

6

The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot study.

Di Leo A, Bajetta E, Nolè F, Biganzoli L, Ferrari L, Oriana S, Riboldi G, Bohm S, Spatti G, Raspagliesi F, et al. Di Leo A, et al. Among authors: bohm s. Br J Cancer. 1994 May;69(5):961-6. doi: 10.1038/bjc.1994.186. Br J Cancer. 1994. PMID: 7514030 Free PMC article. Clinical Trial.

7

Control of nausea and vomiting by granisetron in ovarian cancer patients treated with different cisplatin-based regimens.

Bresciani G, Böhm S, Oriana S. Bresciani G, et al. Among authors: bohm s. Tumori. 1994 Oct 31;80(5):344-7. doi: 10.1177/030089169408000506. Tumori. 1994. PMID: 7839463 Clinical Trial.

8

An intensive treatment with mitoxantrone and ifosfamide in second-line therapy of epithelial ovarian cancer.

Leo AD, Biganzoli L, Bohm S, Lupi G, Oriana S, Riboldi G, Spatti G, Vicario G, Di Re F, Bajetta E. Leo AD, et al. Among authors: bohm s. Tumori. 1994 Dec 31;80(6):443-7. doi: 10.1177/030089169408000607. Tumori. 1994. PMID: 7900234 Clinical Trial.

9

High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer.

Di Re F, Bohm S, Oriana S, Spatti GB, Pirovano C, Tedeschi M, Zunino F. Di Re F, et al. Among authors: bohm s. Ann Oncol. 1993 Jan;4(1):55-61. doi: 10.1093/oxfordjournals.annonc.a058362. Ann Oncol. 1993. PMID: 8435364 Free article. Clinical Trial.

10

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.

Righetti SC, Della Torre G, Pilotti S, Ménard S, Ottone F, Colnaghi MI, Pierotti MA, Lavarino C, Cornarotti M, Oriana S, Böhm S, Bresciani GL, Spatti G, Zunino F. Righetti SC, et al. Among authors: bohm s. Cancer Res. 1996 Feb 15;56(4):689-93. Cancer Res. 1996. PMID: 8630996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

667 results

Search Page

Filters